{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:03:08Z","timestamp":1784782988769,"version":"3.55.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Short-chain fatty acids (SCFAs) are microbiota-derived metabolites implicated in immunometabolic regulation. How their systemic and myocardial signatures diverge during post-infarction remodeling, and how these signatures relate to cardiac fibrosis, remains poorly characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Permanent LAD ligation was performed in male C57BL\/6J mice assigned to five groups: Control (G0), Sham (G1), MI (G2), MI with mixed SCFA gavage from postoperative day 1 (G3), and MI with a high-fiber diet (HFF, G4). Serum and heart tissue were harvested at day 7 and day 28 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095 per group per time point). Targeted SCFA profiling was performed in both compartments. Cardiac fibrosis was evaluated by Masson staining, immunohistochemistry, and qPCR; myocardial energy status by ATP content and NAD\u207a\/NADH ratio; and circulating biomarkers by ELISA. Pathway-related transcripts were measured by qPCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Acetic acid predominated across all groups. MI was associated with an altered serum SCFA profile, and serum profiles separated more clearly by PCA than myocardial profiles, in which hierarchical clustering highlighted a prominent HFF-related shift. MI increased cardiac collagen deposition, an effect attenuated by both SCFA supplementation and HFF, with Collagen III markedly elevated after MI and reduced in the intervention groups. MI caused pronounced ATP depletion at both time points, partially restored by both interventions and more so by HFF. The NAD\u207a\/NADH ratio was more variable at day 7 and converged across groups by day 28. Serum cTnT and BNP rose after MI and were lower in the intervention groups, whereas serum TGF-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      1 did not differ significantly.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Increasing SCFA availability through mixed SCFA supplementation or a high-fiber diet was associated with divergent serum-vs.-cardiac SCFA remodeling, reduced post-MI fibrosis, and improved myocardial energy balance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1858770","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:28:12Z","timestamp":1784780892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mixed short-chain fatty acids and high-fiber diet reshape SCFA profiles and attenuate post-infarction cardiac fibrosis in mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhiyuan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Qingdao University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Qingdao University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunrong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Qingdao University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaidi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"110066","DOI":"10.1016\/j.cellsig.2021.110066","article-title":"Cardiac fibrosis: pathobiology and therapeutic targets","volume":"85","author":"Czubryt","year":"2021","journal-title":"Cell Signal"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1070973","DOI":"10.3389\/fphar.2023.1070973","article-title":"Post-myocardial infarction fibrosis: pathophysiology, examination, and intervention","volume":"14","author":"Yin","year":"2023","journal-title":"Front Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/CIRCRESAHA.125.325516","article-title":"Gut-Heart axis: the role of gut Microbiota and metabolites in heart failure","volume":"136","author":"Snelson","year":"2025","journal-title":"Circ Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"133124","DOI":"10.1016\/j.ijcard.2025.133124","article-title":"Beyond the gut: systemic levels of short-chain fatty acids are altered in patients with heart failure","volume":"428","author":"Palm","year":"2025","journal-title":"Int J Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1038\/s41467-023-43167-5","article-title":"Gut butyrate-producers confer post-infarction cardiac protection","volume":"14","author":"Chen","year":"2023","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/cvr\/cvae128","article-title":"Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischaemic heart disease","volume":"120","author":"Pham","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1046912","DOI":"10.3389\/fmicb.2022.1046912","article-title":"High fiber diet attenuate the inflammation and adverse remodeling of myocardial infarction via modulation of gut microbiota and metabolites","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1638515","DOI":"10.3389\/fcvm.2025.1638515","article-title":"Isoform-specific roles of AMP-activated protein kinase in cardiac physiology and pathophysiology","volume":"12","author":"Rakoubian","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1161\/CIRCULATIONAHA.120.052671","article-title":"Short-Chain fatty acids outpace ketone oxidation in the failing heart","volume":"143","author":"Carley","year":"2021","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"109618","DOI":"10.1016\/j.intimp.2022.109618","article-title":"Propionate alleviated post-infarction cardiac dysfunction by macrophage polarization in a rat model","volume":"115","author":"Zhou","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"875473","DOI":"10.3389\/fnut.2022.875473","article-title":"Butyric acid ameliorates myocardial fibrosis by regulating M1\/M2 polarization of macrophages and promoting recovery of mitochondrial function","volume":"9","author":"Li","year":"2022","journal-title":"Front Nutr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.3390\/ijms25137379","article-title":"The role of short chain fatty acids in inflammation and body health","volume":"25","author":"Du","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B14","doi-asserted-by":"publisher","first-page":"230014","DOI":"10.1098\/rsob.230014","article-title":"Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections","volume":"13","author":"Ney","year":"2023","journal-title":"Open Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/biomedicines11082313","article-title":"Recent advances in Microbiota-associated metabolites in heart failure","volume":"11","author":"Masenga","year":"2023","journal-title":"Biomedicines"},{"key":"B16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/biomedicines13020343","article-title":"Short-Chain fatty acids and their metabolic interactions in heart failure","volume":"13","author":"Chulenbayeva","year":"2025","journal-title":"Biomedicines"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1097\/MS9.0000000000001744","article-title":"Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease","volume":"86","author":"Shariff","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"12465","DOI":"10.3390\/ijms252212465","article-title":"The gut-heart axis: molecular perspectives and implications for myocardial infarction","volume":"25","author":"Rivera","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e72171","DOI":"10.7554\/eLife.72171","article-title":"Short-chain fatty acids activate acetyltransferase p300","volume":"10","author":"Thomas","year":"2021","journal-title":"Elife"},{"key":"B20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jchf.2023.03.008","article-title":"Microbially produced imidazole propionate is associated with heart failure and mortality","volume":"11","author":"Molinaro","year":"2023","journal-title":"JACC Heart Fail"},{"key":"B21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13073-024-01296-6","article-title":"Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity","volume":"16","author":"Raju","year":"2024","journal-title":"Genome Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1038\/s41467-024-50855-3","article-title":"Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of beta2-adrenergic receptors","volume":"15","author":"Saha","year":"2024","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/CIRCRESAHA.123.322381","article-title":"Indole-3-Propionic acid protects against heart failure with preserved ejection fraction","volume":"134","author":"Wang","year":"2024","journal-title":"Circ Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41569-022-00823-5","article-title":"Macrophages in cardiac remodelling after myocardial infarction","volume":"20","author":"Yap","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B25","first-page":"e13956","article-title":"Trigonelline improves metabolism and cardiac function of HFpEF mice via gut microbiome alterations-mediated AMPK activation","volume-title":"Adv Sci (Weinh)","author":"Cheng","year":"2026"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1858770\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:28:14Z","timestamp":1784780894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1858770\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2026.1858770"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1858770","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"1858770"}}